Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study evaluates a new treatment combination of ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory multiple myeloma. Participants will either receive ixazomib with cyclophosphamide and dexamethasone or cyclophosphamide and dexamethasone alone.
Critère d'inclusion
- Multiple myeloma